PINK1 regulates cytoplasmic dynein and mitochondrial transport
PINK1 regulates cytoplasmic dynein and mitochondrial transport
批准号:
10053682
负责人:
Peter Anthony Otero
金额:
$4.5万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-11-01 至 2021-10-31
关键词:
Adaptor Signaling ProteinAffectAlzheimer&aposs DiseaseAutopsyAxonBiochemicalBiological AssayBrain regionCell DeathCell NucleusCellsChronicCytoskeletonDataDementiaDendritesDevelopmentDiseaseDynein ATPaseEnsureGoalsIn VitroIndividualInjuryInvestigationKnockout MiceLewy Body DementiaLinkMeasuresMediatingMicroscopicMicroscopyMicrotubulesMitochondriaMolecularMonitorMovementMutateMutationN-terminalNerve DegenerationNeurodegenerative DisordersNeuronsPTEN geneParkinson DiseaseParkinson&aposs DementiaParkinsonian DisordersPathogenesisPathogenicityPathologyPatientsPhenotypePhosphorylationPhosphotransferasesPlayPrevalenceProcessProteinsPublic HealthRegulationResearch ProposalsRoleSiteStructureSubstantia nigra structureSynapsesTechniquesTestingTrainingVertebral columnWild Type Mouseage related neurodegenerationaging demographicdopaminergic neurongene productin vivoinsightloss of functionmutantneuronal cell bodynovelnovel therapeutic interventionpre-doctoralpreventsynaptic function
中文摘要
项目总结/摘要
帕金森病(PD)/帕金森病痴呆(PDD)是第二常见的慢性,
神经退行性疾病其特征在于黑质多巴胺能神经元的丧失,
通常伴随着病变扩展到皮层。这种变性的致病机制
仍然知之甚少,尽管对家族性帕金森病中突变的基因产物的分析,
有助于我们对PD/PDD发病机制的理解。这些PD相关基因产物之一,PTEN
诱导的激酶1(PINK 1)已显示可防止由帕金森病损伤诱导的细胞死亡。但
对这种保护的基本机制仍然知之甚少。我的初步数据显示,PINK 1
调节线粒体从索马进入树突。我还发现PINK 1调节
细胞质动力蛋白的磷酸化。这些发现使我假设PINK 1促进了
通过调节动力蛋白的磷酸化将线粒体转运到树突。我将使用先进的显微镜,
生物化学和分子技术,以确定新的PINK 1是否调节磷酸化,
动力蛋白调节其对线粒体转运的作用。我还将研究PD相关PINK 1的影响
动力蛋白磷酸化和线粒体转运的突变。除了为我提供博士预科
训练,这项研究建议将有助于阐明PINK 1调节线粒体的机制,
分布在神经元和提供洞察PD/PDD发病机制的基础。
英文摘要
Project Summary/Abstract
Parkinson’s disease (PD)/Parkinson’s disease dementia (PDD) is the second most common chronic,
neurodegenerative disorder. It is characterized by the loss of dopaminergic neurons from the substantia nigra,
often with extension of pathology into the cortex. The pathogenic mechanism underlying this degeneration
remains poorly understood, though analysis of gene products mutated in familial parkinsonisms has
contributed to our understanding of PD/PDD pathogenesis. One of these PD-associated gene products, PTEN
induced kinase 1 (PINK1), has been shown to prevent cell death induced by parkinsonian injury. However, the
mechanisms underlying this protection remain poorly understood. My preliminary data indicate that PINK1
regulates mitochondrial egress from the soma into the dendrites. I have also found that PINK1 regulates
phosphorylation of cytoplasmic dynein. These discoveries have led me to hypothesize that PINK1 promotes
mitochondrial transport into dendrites by regulating phosphorylation of dynein. I will use advanced microscopic,
biochemical, and molecular techniques to determine whether the novel PINK1 regulated phosphorylation of
dynein regulates its effects on mitochondrial transport. I will also study the impact of PD-linked PINK1
mutations on dynein phosphorylation and mitochondrial transport. In addition to providing me with predoctoral
training, this research proposal will help elucidate mechanisms by which PINK1 regulates mitochondrial
distribution in neurons and provide insight into mechanisms underlying PD/PDD pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金